Evidence map›Paper›PMID 30636329›Full record

ArticleProtein science : a publication of the Protein Society2019

Chemically reprogramming the phospho-transfer reaction to crosslink protein kinases to their substrates.

Allison W Wong, Anatoly Urisman, Alma L Burlingame, Kevan M Shokat

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Allison W WongDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California.
Anatoly UrismanDepartment of Pathology, University of California San Francisco, San Francisco, California.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California.
Kevan M ShokatDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California.
University of California, San Francisco · USUniversity of San Francisco · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Layered post-translational modifications provide a tuning method for ubiquitylationF30CA213979 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WONG, ALLISON · 2017 to 2018
$80k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA213979NCI NIH HHS F30CA213979NIGMS NIH HHS T32 GM007618
6 · The paper itself

Abstract

The proteomic mapping of enzyme-substrate interactions is challenged by their transient nature. A method to capture interacting protein kinases in complexes with a single substrate of interest would provide a new tool for mapping kinase signaling networks. Here, we describe a nucleotide-based substrate analog capable of reprogramming the wild-type phosphoryl-transfer reaction to produce a kinase-acrylamide-based thioether crosslink to mutant substrates with a cysteine nucleophile substituted at the native phosphorylation site. A previously reported ATP-based methacrylate crosslinker (ATP-MA) was capable of mediating kinase crosslinking to short peptides but not protein substrates. Exploration of structural variants of ATP-MA to enable crosslinking of protein substrates to kinases led to the discovery that an ADP-based methacrylate (ADP-MA) crosslinker was superior to the ATP scaffold at crosslinking in vitro. The improved efficiency of ADP-MA over ATP-MA is due to reduced inhibition of the second step of the kinase-substrate crosslinking reaction by the product of the first step of the reaction. The new probe, ADP-MA, demonstrated enhanced in vitro crosslinking between the Src tyrosine kinase and its substrate Cortactin in a phosphorylation site-specific manner. The kinase-substrate crosslinking reaction can be carried out in a complex mammalian cell lysate setting, although the low abundance of endogenous kinases remains a significant challenge for efficient capture.

Indexed as

Adenosine TriphosphateAnimalsChickensCortactinCross-Linking ReagentsCysteineHEK293 CellsHumansKineticsMethacrylatesModels, MolecularPeptidesPhosphorylationProtein Conformationsrc-Family KinasesStructure-Activity RelationshipAdenosine TriphosphateCortactinCross-Linking ReagentsCysteineMethacrylatesPeptidessrc-Family Kinaseschemical geneticskinase-substrate interactionsmass spectrometryphosphorylationprotein kinasessignaling networks

Identifiers

PMID30636329
PMCPMC6371225
OpenAlexW2909203478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.